Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy

6 Dec 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38055267
DOI: 10.1056/nejmc2312288

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular DystrophyPMID 38055267Read ↗

Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivatorSemantic proximity Read ↗

Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophySemantic proximity Read ↗

Lung endothelial transduction in a patient that succumbed to acute respiratory distress syndrome following high-dose rAAV9 gene therapySemantic proximity Read ↗

Advances in Duchenne muscular dystrophy gene therapySemantic proximity Read ↗

Food and Drug Administration Lifts Clinical Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy Linked to Patient DeathSemantic proximity Read ↗

Gene therapy review: Duchenne muscular dystrophy case study.Semantic proximity Read ↗

Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy.Semantic proximity Read ↗

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.Semantic proximity Read ↗

Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSemantic proximity Read ↗

After Patient Death, FDA Places Hold on Pfizer Duchenne Muscular Dystrophy Gene Therapy TrialSemantic proximity Read ↗

Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in FocusSemantic proximity Read ↗

Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.